Jason Krystofiak, MD
Sports Medicine · Livingston, NJNPI 1679991145
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $24,532 of the $31,279 with a category attached, or 78.4%. Biotissue Holdings Inc. accounts for 91.6% of it on its own, with 28 other manufacturers making up the rest. Among sports medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $220.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$29K
- Pacira Pharmaceuticals Incorporated$717
- Bioventus LLC$295
- Novo Nordisk$259
- Ferring Pharmaceuticals Inc.$235
- AstraZeneca$217
- plus $898 from 23 others
What the payments were for
- Consulting fees$24,53278%
- Travel & lodging$4,39414%
- Food & beverage$2,3478%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 13 | $28,659 |
| Pacira Pharmaceuticals Incorporated | 5 | $717 |
| Bioventus LLC | 11 | $295 |
| Novo Nordisk | 22 | $259 |
| Ferring Pharmaceuticals Inc. | 15 | $235 |
| AstraZeneca | 17 | $217 |
| GSK | 7 | $101 |
| Avanos Medical | 3 | $81 |
| Johnson & Johnson(2 entities) | 4 | $77 |
| Amgen(2 entities) | 5 | $62 |
| Merz Pharmaceuticals, LLC | 3 | $58 |
| Pacira Therapeutics, Inc. | 4 | $57 |
| Pfizer | 4 | $56 |
| AbbVie | 3 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $40 |
| Kowa Pharmaceuticals America, Inc. | 3 | $36 |
| IBSA Pharma Inc. | 2 | $35 |
| Fidia Pharma USA Inc. | 2 | $32 |
| Boehringer Ingelheim | 2 | $28 |
| Lilly USA, LLC | 2 | $28 |
| Amarin Pharma, Inc. | 2 | $27 |
| Vivus LLC | 2 | $24 |
| Merck | 2 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Abbott | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,279 in reported general payments places this provider in the 90th percentile of 221 sports medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 18 | $71 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Livingston
- Sean McMillanBurlington$1.8M
- Nicholas JarmonFreehold$277K
- Thomas YoumEnglewood$221K
- Stephen HuntCedar Knolls$76K
- David PorterHackensack$63K
- Francis AlbertaHackensack$61K
- Nathan HolmesSewell$56K
- Steven FreyWoodbury$55K
- Lon CastleFranklin Lakes$54K
- Dante MarconiSomers Point$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.